<乌鸦传媒>Improving Small Bowel Capsule Endoscopy Visualization Meta-analysis shows 15% improvement in adequate small bowel cleansing with purgative preparations Jul 26, 2022
<乌鸦传媒>TNF Inhibitors, Thiopurines May Help Reduce Recurrent Acute Arterial Events IBD patients with previous events saw lower risk of recurrence, according to French study Jul 19, 2022
<乌鸦传媒>Genotype Tied to Azathioprine Discontinuation for Toxicity Nearly threefold risk seen with a genotype most common among Black patients Jun 20, 2022
<乌鸦传媒>FDA OKs Risankizumab for Crohn's Disease Approval marks the third indication for the IL-23 inhibitor in adults Jun 17, 2022
<乌鸦传媒>Appendectomy Linked to Higher Risk of Microscopic Colitis Risk remained elevated over 10 years, Swedish study showed Jun 17, 2022
<乌鸦传媒>Biologics for Crohn's Go Head to Head Ustekinumab, adalimumab both effective in SEAVUE trial, with no difference in remissions Jun 13, 2022
<乌鸦传媒>Risankizumab Eases Moderate to Severe Crohn's Disease Induction and maintenance trials showed higher clinical remission with subcutaneous and IV doses Jun 06, 2022
<乌鸦传媒>Maintenance Mirikizumab Proves Mettle in Ulcerative Colitis In LUCENT-2, clinical remissions doubled among responders to induction therapy May 26, 2022
<乌鸦传媒>Etrasimod Shows Promise in Moderate to Severe Ulcerative Colitis Analysis of two ELEVATE trials showed significant improvements in clinical remission May 25, 2022
<乌鸦传媒>Antibiotics Heighten Risk for IBD in Seniors Registry-based study finds association with antibiotics that target gastrointestinal pathogens May 13, 2022
<乌鸦传媒>Unusual Hepatitis Spreads; IBD and Erectile Dysfunction; Can PFAS Harm Livers? News and commentary from the world of gastroenterology and hepatology Apr 28, 2022
<乌鸦传媒>Perianal Fistulas in Crohn's Signal Greater Disease Burden U.S. registry finds greater medication use and twice as many IBD-related surgeries Apr 27, 2022
<乌鸦传媒>Pregnant Woman With Crohn's Disease Experiences Perianal Pain Pain may be sole symptom of Fournier's gangrene in the immunosuppressed Apr 25, 2022
<乌鸦传媒>Crohn's Fistulas Heal Better With Combined Surgical-TNF Blocker Approach Some, but not all, key outcomes prove better in clinical trial Apr 18, 2022
<乌鸦传媒>Pre-Op TNF Blockers Cleared of Infection Risk in IBD Patients Largest prospective cohort study finds no increase in postoperative infections Apr 14, 2022
<乌鸦传媒>Rinvoq Approved for UC; HCC Combo Flops; Disney Grants Pass to IBS Patient News and commentary from the world of gastroenterology and hepatology Mar 17, 2022
<乌鸦传媒>Kids With IBD Need Close Monitoring as They Grow Up Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
<乌鸦传媒>Surveillance Colonoscopy in IBD Tied to Lower Advanced Cancer Risk Findings bolster guidelines for IBD patients with extensive colitis or left-sided colitis Mar 01, 2022
<乌鸦传媒>Ulcerative Colitis With an Unexpected Cause Can the immune response to COVID-19 trigger inflammatory bowel disease? Mar 01, 2022
<乌鸦传媒>SubQ Infliximab Works for IBD; FDA Clears Complex Colonoscopy Tool; IBS & Diet News and commentary from the world of gastroenterology and hepatology Feb 18, 2022
<乌鸦传媒>Guselkumab Cuts Disease Activity in Crohn's Nearly two-thirds of patients respond to selective p19 IL-23 inhibitor Feb 08, 2022
<乌鸦传媒>Trial Data Confirm Heightened Risks With JAK Inhibitor May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
<乌鸦传媒>Simpler Tool Validated for Endoscopic Assessment in Crohn's SEMA-CD should be used as endpoint for clinical trials, researcher argues Jan 26, 2022
<乌鸦传媒>Vedolizumab for Ulcerative Colitis Works Best When Given Early Benefit confirmed in real-world data Jan 25, 2022
<乌鸦传媒>Combo Treatment Disappoints in Acute Severe Ulcerative Colitis No outcomes boost with addition of 5-ASA agent to corticosteroids in hospitalized patients Jan 23, 2022
<乌鸦传媒>Patients With IBD Cite Symptom Relief With Online Intervention Tool But experts warns that patients were on the very strict Specific Carbohydrate Diet Jan 22, 2022
<乌鸦传媒>Which IBD Patients Experience More Severe COVID? Research suggests immunomodulators, incomplete vaccination, and non-mRNA vaccines may play a role Jan 21, 2022
<乌鸦传媒>Crohn's Disease Scores With Interchangeable Humira Biosimilar "Non-medical switches" will be less of a concern when new treatment option becomes available Dec 31, 2021
<乌鸦传媒>Non-Invasive Nerve Stimulation Shows Promise for Younger IBD Patients Small pilot study found many children and young adults achieved clinical remission Dec 15, 2021
<乌鸦传媒>Year in Review: Crohn's Disease First interchangeable biosimilar approved, biologics go head-to-head Dec 15, 2021
<乌鸦传媒>For IBD Patients, Too Much Processed Meat May Be Deadly Study investigates diet's link to all-cause mortality, not just IBD incidence Dec 14, 2021
<乌鸦传媒>No Extra C. Diff Risk Observed With Vedolizumab in Ulcerative Colitis Retrospective study found no increased risk versus anti-TNF agents, but more research is needed Dec 11, 2021
<乌鸦传媒>Time Doesn't Heal Parents' Mental Health Wounds From Kids' IBD Dx "I was surprised" by these results, researcher says Dec 10, 2021
<乌鸦传媒>Biologics vs Small Molecule Drugs for UC: Which Agent Emerged on Top? The most effective drug not necessarily the safest Dec 01, 2021
<乌鸦传媒>JAK Inhibitor Maintenance Works in Severe Ulcerative Colitis Treatment group achieved clinical remission, met clinical secondary endpoints Oct 29, 2021
<乌鸦传媒>Maintenance IL-23 Blockade Yields Durable Benefit in Crohn's Disease Over 50% of patients responding to induction risankizumab maintained clinical remission at 1 year Oct 28, 2021
<乌鸦传媒>How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
<乌鸦传媒>First Interchangeable Humira Biosimilar Approved Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
<乌鸦传媒>IBD and Pediatric Arthritis: Exploring the Link Risk factors include enthesitis, family history, and etanercept use Sep 15, 2021
<乌鸦传媒>FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risks Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
